Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
Heavy social media use appears to be contributing to the drop in wellbeing among young people in English-speaking countries and Western Europe, especially among girls, according to findings published today (19 March) in the 2026 edition of the World Happiness Report.
A new research centre backed with \u00a311 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs.
New investment at Oxford\u2019s Nuffield Department of Primary Care Health Sciences will support academic leadership, research capacity and training in Tunisia
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative study led by the University of Oxford and University of Antwerp, report that point-of-care diagnostic testing, when used alone is unlikely to reduce antibiotic prescribing for respiratory tract infections in primary care. The findings indicate that testing must be embedded within broader antimicrobial stewardship strategies to be effective.
Departments across Medical Sciences have been celebrating International Women\u2019s Day (8 March) by highlighting women driving progress in science and global health.
The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world\u2019s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.
Two companion studies, published in Cell Genomics, reveal how brain development lays the foundation for both shared and sex-specific circuits, redefining how neural diversity arises. A Preview article linked to the report highlights the broader significance of these findings and places them in context for the field.
The World Health Organization (WHO) has designated the Nuffield Department of Primary Care Health Sciences at the University of Oxford as the WHO Collaborating Centre on Primary Health Care.
Research published today in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body\u2019s own defence systems are helping them to thrive.
Research led by the Nerlov Group in the Medical Research Council (MRC) Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Researchers at the Kennedy Institute of Rheumatology have found that physically resisting the formation of an immunological synapse actually promotes a stronger immune response. The findings could help explain how immune responses become weakened in cancer and chronic infection and inform the design of more effective vaccines.
Ester Hammond, Professor of Molecular Cancer Biology in the Department of Oncology, has been awarded new funding from Brain Research UK to investigate much needed treatment options for paediatric high-grade glioma (pHGG), the most common cause of tumour-related death in children.
An innovative new collaboration between the University of Oxford and the Eden Project will investigate how nature can improve mental health and wellbeing.
Women are central to scientific discovery and academic leadership worldwide, contributing as researchers, clinicians, educators and technical specialists across the global research community. Their work advances knowledge and strengthens health systems to ensure that science reflects the diverse societies it aims to serve.
To mark International Women\u2019s Day 2026, the Nuffield Department of Primary Care Health Sciences highlights the contributions of two of their researchers to a major new Parliamentary report on menstrual health.
The latest national maternity survey, You & Your Baby 2024, provides a picture of the mental health and maternity care experiences of women who gave birth in England in May 2024. We heard from 3,728 women from across the country - 3 in 10 were from minority ethnic groups, 3 in 10 were born outside the UK, and 2 in 10 lived in the most disadvantaged areas.
Researchers at the University of Oxford have developed a \u201cStroke Cognition Calculator\u201d, a new tool designed to estimate a person\u2019s chance of having thinking and memory problems six months after a stroke.
![\"Microscope\"](\"https://www.medsci.ox.ac.uk/news/oxford-university-spinout-dark-blue-therapeutics-acquired-to-advance-leukaemia-treatment/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n